1) refractory chronic lymphocytic leukemia
难治性慢性淋巴细胞白血病
1.
To investigate the curative effects of high-dose methylprednisolone (HDMP) in the treatment of refractory chronic lymphocytic leukemia (CLL), 5 patients with CLL who poorly reacted to several cycles of fludarabine based protocols with or without rituximab were treated with 1 to 6 cycles of HDMP with 1 g/(m2·d) for d1-5.
为探讨大剂量甲基泼尼松龙(HDMP)对难治性慢性淋巴细胞白血病(CLL)的治疗效果,采用HDMP(1g/m2。
3) Chronic lymphocytic leukemia
慢性淋巴细胞白血病
1.
Study of immunophenotype in chronic lymphocytic leukemia;
慢性淋巴细胞白血病的免疫表型研究
2.
Detection of p53 gene deletion in chronic lymphocytic leukemia by fluorescence in situ hybridization;
荧光原位杂交技术检测慢性淋巴细胞白血病p53基因的缺失
3.
Analysis and clinical significance of natural kill cell and T lymphocyte subsets in chronic lymphocytic leukemia;
慢性淋巴细胞白血病患者外周血T淋巴细胞亚群及NK细胞亚群分析及临床意义
4) CLL
慢性淋巴细胞白血病(CLL)
5) T cell chronic lymphocytic (leukemia) (TCCL)
慢性T淋巴细胞(白血病)
补充资料：慢性淋巴细胞性白血病
慢性淋巴细胞性白血病
简称"慢淋"。系免疫无能的小淋巴细胞恶性增殖性疾病。起病比慢粒更缓慢，临床表现更为多样化。早期常无症状或仅有轻度不适，可在体检或血细胞检验时偶然发现。首发症状为淋巴结肿大，其次为乏力、消瘦等。全身症状如发热、盗汗、瘙痒等多为疾病进展的征象。待疾病晚期贫血及出血同时出现。本病预后相对良好，患者又多为老年，所以不必由于淋巴细胞增多而急于治疗。症状明显者，一般采用化疗和放射治疗等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条